切换至 "中华医学电子期刊资源库"
高级检索
中华产科急救电子杂志

中华产科急救电子杂志 ›› 2014, Vol. 03 ›› Issue (03) : 159 -162. doi: 10.3877/cma.j.issn.2095-3259.2014.03.002

所属专题： 文献；

专家论坛

乙型肝炎病毒DNA检测在孕期的应用
曾映夫1, 林潮双1,†()   
  1. 1. 510630　广州，中山大学附属第三医院感染科
  • 收稿日期:2014-06-15 出版日期:2014-08-18
  • 通信作者: 林潮双

Application of hepatitis B virus DNA detection in pregnancy

Yingfu Zeng1, Chaoshuang Lin1()   

  • Received:2014-06-15 Published:2014-08-18
  • Corresponding author: Chaoshuang Lin
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

曾映夫, 林潮双. 乙型肝炎病毒DNA检测在孕期的应用[J]. 中华产科急救电子杂志, 2014, 03(03): 159-162.

Yingfu Zeng, Chaoshuang Lin. Application of hepatitis B virus DNA detection in pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(03): 159-162.

孕妇血清乙型肝炎病毒(hepatitis B virus, HBV)DNA水平目前被认为是预测发生HBV母婴垂直传播的一个最重要指标和独立的危险因素。普遍认为，在充分考虑对孕妇及胎儿的利与弊的前提下，妊娠中、晚期口服安全性较高的核苷(酸)类抗病毒药物，可在分娩前明显降低母血中HBV DNA载量，从而最大程度地阻断HBV母婴垂直传播。抗病毒治疗4周后监测HBV DNA载量可以预估核苷(酸)类药物抗病毒治疗的远期有效性，以便及时调整治疗方案。HBV DNA检测在孕期的应用与何时应用对阻断HBV母婴垂直传播具有重要意义。

关键词: 肝炎病毒，乙型, 妊娠, 疾病传播，垂直, 嗜肝DNA病毒科

Maternal serum hepatitis B virus (HBV) DNA level is considered as the most important and independent risk factor to predict the HBV vertical transmission rates. After fully considered the pros and cons of the mother and fetus, it′s generally agreed that administration of oral nucleoside antiviral in the second and third trimester can significantly reduce maternal serum HBV loads before delivery. Consequently, it will prevent maternal-fetal transmission of HBV to the maximum extent. HBV DNA level at week 4 of antiviral treatment predicts the long-term efficacy, which conduce to improve the therapeutic schedule. Overall, the measurement of HBV DNA level during pregnancy and the optimal time have important meaning for preventing maternal-fetal transmission of HBV.

Key words: Hepatitis B virus, Pregnancy, Disease transmission, vertical, Hepadnaviridae
[1]
Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11):1118-1129.
[2]
Bzowej NH. Hepatitis B therapy in pregnancy[J]. Curr Hepat Rep, 2010, 9(4):197-204.
[3]
Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities[J]. Korean J Hepatol, 2011, 17(1):1-8.
[4]
Lai CL, Ratziu V, Yuen MF, et al. Viral hepatitis B[J]. Lancet, 2003, 362(9401):2089-2094.
[5]
Lee C, Gong Y, Brok J, et al. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis[J]. BMJ, 2006, 332 (7537): 328-336.
[6]
Burk RD, Hwang LY, Ho GY, et al. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load[J]. J Infect Dis, 1994, 170(6):1418-1423.
[7]
Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants[J]. J Viral Hepat, 2011, 18(7): 468-473.
[8]
Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus：an Australian experience[J]. Med J Aust, 2009, 190(9): 489-492.
[9]
Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers[J]. J Viral Hepat, 2012, 19(2):e18-e25.
[10]
Thibault V, Pichoud C, Mullen C, et al. Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infections[J]. J Clin Microbiol, 2007, 45(12):3948-3953.
[11]
丁世涛，汤影子. 不同方法检测血清HBV DNA水平比较[J]. 现代生物医学进展，2011, 10(19):3658-3659.
[12]
Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B[J]. N Engl J Med, 2007, 357(25): 2576-2588.
[13]
Zheng Q, Jang JJ, Chen J, et al. Serum HBV DNA level at week 24 as a proper predictor for the effect of 2-year lamivudine treatment[J]. Clin Med J (Engl), 2011, 124(8):1257-1260.
[14]
Yuen MF, Fong DY, Wong DK, et al. Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response[J]. Hepatology, 2007, 46(6):1695-1703.
[15]
杨柳絮，赵中夫. 拉米夫定治疗4周检测乙型肝炎病毒DNA水平预测104周疗效的价值[J]. 中国药物与临床，2011, 11(7):784-786.
[16]
Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment[J]. Gastroenterol Clin North Am, 2011, 40(2):355-372.
[17]
Mahtab MA, Rahman S, Khan M, et al. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(2):161-164.
[18]
Tse KY, Ho LF, Lao T, el al. The impact of maternal HBsAg carrier status on pregnancy outcomes：a case-control study[J]. J Hepatol, 2005, 43(5):771-775.
[19]
Wong S, Chan LY, Yu V, et al. Hepatitis B carrier and perinatal outcome in singleton pregnancy[J]. Am J Perinatol, 1999, 16(9):485-488.
[20]
Safir A, Levy A, Sikuler E, et al. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome[J]. Liver Int, 2010, 30(5):765-770.
[1] 危玲, 李会, 陈奕. 孕产妇产超广谱β-内酰胺酶的肠杆菌定植/感染与母婴传播研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 517-521.
[2] 杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[3] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[4] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[5] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[6] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[7] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[8] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[9] 王迎迎, 谢平. 乙型肝炎病毒感染合并肺结核患者发生肝损伤的危险因素及预测模型构建[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 267-273.
[10] 王跃, 唐敏, 李鹏超, 吕强. 妊娠期膀胱副神经节瘤伴严重出血一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 410-411.
[11] 胡金科, 钟文. 妊娠期输尿管结石的处理与转归[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 377-381.
[12] 陈淑钿, 梁韵, 廖媛, 王杨. 补体C3在HBV相关慢加急性肝衰竭患者预后评估中的价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 562-566.
[13] 杨聚荣. 透析患者妊娠的管理[J]. 中华肾病研究电子杂志, 2023, 12(05): 300-300.
[14] 张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
[15] 邹艳丽, 栾文杰, 王淑娟, 刘亚琴, 初桂芝, 李松洋, 王好玲, 张锦婷, 姜鑫, 栾泽东. 早孕期胎儿右位主动脉弓的产前超声诊断学特征[J]. 中华诊断学电子杂志, 2023, 11(04): 227-232.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号